![Brian Leuthner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian Leuthner
Fondateur chez
Alivio Therapeutics, Inc.
Profil
Brian A. Leuthner is the founder.
He founded Edge Therapeutics, Inc. in 2009 and held the title of President, Chief Executive Officer & Director.
Mr. Leuthner is also the founder of Alivio Therapeutics, Inc. Mr. Leuthner's former job(s) include being the Chief Executive Officer of Fontus Pharmaceuticals, Inc. from 2007 to 2008, Director-Market Development at ESP Pharma, Inc. from 2003 to 2005, and Senior Head-Marketing at The Medicines Co. from 2005 to 2007.
He also briefly served as the Chief Executive & Operating Officer at OncoSec Medical, Inc. in 2021.
Additionally, Mr. Leuthner held positions at Ortho Biotech Products LP and PDS Biotechnology Corp., with the title of Principal and Chief Executive Officer, respectively.
Mr. Leuthner's education history includes undergraduate studies and an MBA from The University of North Carolina at Chapel Hill.
Postes actifs de Brian Leuthner
| Sociétés | Poste | Début |
|---|---|---|
Alivio Therapeutics, Inc.
 Alivio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat inflammatory disorders through targeted disease immunomodulation | Fondateur | - |
Anciens postes connus de Brian Leuthner
| Sociétés | Poste | Fin |
|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Directeur Général | 13/08/2021 |
Fontus Pharmaceuticals, Inc. | Directeur Général | 01/01/2008 |
| THE MEDICINES COMPANY | Sales & Marketing | 01/01/2007 |
ESP Pharma, Inc.
 ESP Pharma, Inc. Pharmaceuticals: MajorHealth Technology Produces pharmaceutical products | Corporate Officer/Principal | 01/01/2005 |
| PDS BIOTECHNOLOGY CORPORATION | Directeur Général | - |
Formation de Brian Leuthner
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
24
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
ESP Pharma, Inc.
ESP Pharma, Inc. Pharmaceuticals: MajorHealth Technology Produces pharmaceutical products | Health Technology |
OncoSec Medical, Inc.
 OncoSec Medical, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel immunotherapeutic products for immuno-oncology treatment | Health Technology |
Edge Therapeutics, Inc.
 Edge Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops therapies | Health Technology |
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ortho Biotech Products LP
 Ortho Biotech Products LP Pharmaceuticals: MajorHealth Technology Provides innovative products and services to help enhance patients health | Health Technology |
Fontus Pharmaceuticals, Inc. | |
Alivio Therapeutics, Inc.
Alivio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat inflammatory disorders through targeted disease immunomodulation | Health Technology |
PDS Biotechnology Corp.
 PDS Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Develops clinical-stage immunotherapies to treat various early-stage and late-stage cancers which includes head & neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer and related cancers | Health Technology |
